Clinical Trials Logo
  1. Home
  2. Peripheral Neuropathic Pain
  3. NCT04171453

Post-marketing Surveillance (PMS) to Observe the Safety and Effectiveness of Lyrica CR Extended Release Tablets

Peripheral Neuropathic Pain Clinical Trial

Official title:
POST-MARKETING SURVEILLANCE (PMS) TO OBSERVE THE SAFETY AND EFFECTIVENESS OF LYRICA(REGISTERED) CR EXTENDED RELEASE TABLETS

Clinical Trial Summary

This is an open-label, non-comparative, non-interventional, prospective, and multi-center PMS study to observe safety and effectiveness of Lyrica CR (82.5mg, 165mg, 330mg) in Korean subjects under the actual condition of use. PMS is an obligation to K-MFDS.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04171453
Study type Observational
Source Viatris Inc.
Contact Nam-Eun Kim
Phone 82-10-9310-7990
Email Nam-Eun.Kim@viatris.com
Status Recruiting
Phase
Start date February 3, 2020
Completion date July 14, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT03733886 - Burst Spinal Cord Stimulation for Neuropathic Pain. N/A
Completed NCT04494815 - A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419 Phase 1/Phase 2
Recruiting NCT04431778 - Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain Phase 2
Completed NCT03191136 - Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Volunteers Phase 1
Completed NCT02100046 - Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain. Phase 2
Completed NCT05416931 - ACD440 Gel in Peripheral Neuropathic Pain Phase 2
Completed NCT06234917 - Increasing Sensori-Motor Rhythm Activity by EEG-Neurofeedback to Reduce the Impact of Pain on Daily Functioning N/A
Completed NCT03009500 - Randomized Controlled Trial of Efficacy and Safety of Local Anesthetics and Steroids for Chronic Peripheral Post-traumatic Neuropathic Pain Phase 3
Completed NCT01524796 - NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions in Denmark
Completed NCT02985216 - Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain Phase 3
Completed NCT01737294 - Observation of the Use of QUTENZA™ in Standard Clinical Practice N/A
Active, not recruiting NCT05890053 - To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral Neuralgia Phase 3
Completed NCT05219812 - A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain Phase 2
Terminated NCT01293851 - Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage
Completed NCT02209896 - BlueWind Reprieve System for the Treatment of PNP N/A
Completed NCT01240148 - Determine the Effect of AZD3161,Injected Intradermally, on Quantitative Sensory Testing Variables in Normal and Ultraviolet-C (UVC) Exposed Skin in Healthy Volunteers Phase 1
Recruiting NCT05817591 - Response Profiles to High-concentration Capsaicin Desensitization in Patients With Peripheral Neuropathic Pain With or Without Allodynia: a Regional Multicenter Prospective Cohort